K2J2 Centrum Medyczne

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Sjögren's disease1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Argenx1 trial
• Bristol-Myers Squibb1 trial
• Inmunotek S.L.1 trial

Running trials

• Not yet recruiting

  Clinical trial to assess the efficacy and safety of a vaccine for grass pollen allergy.

  2026-526100-73-00· Phase 3· Inmunotek S.L.· Source

• Active, not recruiting

  A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

  NCT04908202· Phase 3· Bristol-Myers Squibb· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting

Closed trials

• Completed

  A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)

  NCT06684847· Phase 3· Argenx· Source